IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$241M
AUM Growth
+$40.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
92
New
Increased
Reduced
Closed

Top Buys

1
+$11.8M
2
+$9.81M
3
+$7M
4
RCUS icon
Arcus Biosciences
RCUS
+$3.8M
5
BTAI icon
BioXcel Therapeutics
BTAI
+$3.78M

Top Sells

1
+$12.8M
2
+$5.03M
3
+$4.98M
4
SAGE
Sage Therapeutics
SAGE
+$3.44M
5
SCPH
scPharmaceuticals
SCPH
+$3.13M

Sector Composition

1 Healthcare 99.4%
2 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$3.21M 1.33%
+25,000
27
$2.85M 1.18%
+137,987
28
$2.59M 1.07%
67,805
-90,000
29
$2.41M 1%
+156,000
30
$1.91M 0.79%
203,156
-260,000
31
$1.82M 0.76%
460,416
-395,200
32
$1.56M 0.65%
+422,625
33
$1.38M 0.57%
254,945
-95,055
34
$1.31M 0.54%
46,462
-50,000
35
$1.08M 0.45%
6,874
36
$1.05M 0.44%
85,200
37
$1.02M 0.42%
139,565
-310,841
38
$1M 0.42%
78,348
+16,874
39
$910K 0.38%
+650,000
40
$726K 0.3%
62,766
-100,000
41
$562K 0.23%
200,000
-65,000
42
$515K 0.21%
221,830
43
$506K 0.21%
188,664
44
$494K 0.21%
260,087
45
$427K 0.18%
49,031
46
$375K 0.16%
156,203
47
$363K 0.15%
15,582
48
$357K 0.15%
+10,000
49
$347K 0.14%
11,638
-7,316
50
$323K 0.13%
448,101
1
2
3 4